1. Zou, Tao, Zhou, Meng, Gupta, Akansha, Cherniack, Andrew D, Meyerson, Matthew. 2024. XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells. In Cell reports, 43, 113600. doi:10.1016/j.celrep.2023.113600. https://pubmed.ncbi.nlm.nih.gov/38261514/
2. Begley, Victoria, Jordán-Pla, Antonio, Peñate, Xenia, Pérez-Ortín, José E, Chávez, Sebastián. 2020. Xrn1 influence on gene transcription results from the combination of general effects on elongating RNA pol II and gene-specific chromatin configuration. In RNA biology, 18, 1310-1323. doi:10.1080/15476286.2020.1845504. https://pubmed.ncbi.nlm.nih.gov/33138675/
3. Selinger, Martin, Věchtová, Pavlína, Tykalová, Hana, Štěrba, Ján, Grubhoffer, Libor. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. In Computational and structural biotechnology journal, 20, 2759-2777. doi:10.1016/j.csbj.2022.05.052. https://pubmed.ncbi.nlm.nih.gov/35685361/
4. Larimer, F W, Stevens, A. . Disruption of the gene XRN1, coding for a 5'----3' exoribonuclease, restricts yeast cell growth. In Gene, 95, 85-90. doi:. https://pubmed.ncbi.nlm.nih.gov/1979303/
5. Jones, Christopher Iain, Zabolotskaya, Maria Vasilyevna, Newbury, Sarah Faith. 2012. The 5' → 3' exoribonuclease XRN1/Pacman and its functions in cellular processes and development. In Wiley interdisciplinary reviews. RNA, 3, 455-68. doi:10.1002/wrna.1109. https://pubmed.ncbi.nlm.nih.gov/22383165/
6. Ran, Xue-Bin, Ding, Ling-Wen, Sun, Qiao-Yang, Jha, Sudhakar, Koeffler, H Phillip. . Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy. In Cancer research, 83, 922-938. doi:10.1158/0008-5472.CAN-21-3052. https://pubmed.ncbi.nlm.nih.gov/36638333/